SCHEMBL7607069

SCHEMBL7607069

CCC(N1CCOCC1)n1cnc(-c2ccc(F)cc2)c1-c1ccnc(N)n1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 18/20 0.63
MAPK13 O15264 7/20 0.60
MAPK12 P53778 7/20 0.60
MAPK11 Q15759 7/20 0.60
CSNK1D P48730 3/20 0.49
CSNK1E P49674 2/20 0.49
EGFR P00533 1/20 0.49
KCNH2 Q12809 1/20 0.49
RIPK2 O43353 1/20 0.48
DYRK3 O43781 1/20 0.48
PRKD3 O94806 1/20 0.48
MAP4K4 O95819 1/20 0.48
PRKCG P05129 1/20 0.48
LCK P06239 1/20 0.48
LYN P07948 1/20 0.48
RET P07949 1/20 0.48
PIM1 P11309 1/20 0.48
PRKACA P17612 1/20 0.48
MAPK1 P28482 1/20 0.48
FLT4 P35916 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24171071 0.87 MAPK14 (0.63) MAPK14MAPK13MAPK12MAPK11
SCHEMBL7611282 0.85 MAPK14 (0.65) MAPK14MAPK13MAPK12MAPK11
SCHEMBL8860264 0.82 MAPK14 (0.59) MAPK14MAPK13MAPK12MAPK11
SCHEMBL4916571 0.78 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11CSNK1D
SCHEMBL4915298 0.75 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11
SCHEMBL24171072 0.75 MAPK14 (0.72) MAPK14MAPK13MAPK12MAPK11
SCHEMBL8860473 0.75 MAPK14 (0.54) MAPK14MAPK13MAPK12MAPK11KDR
SCHEMBL20550895 0.74 MAPK14 (0.71) MAPK14MAPK13MAPK12MAPK11CSNK1D
Morpholine SCHEMBL7458976 0.74 MAPK14 (0.68) MAPK14MAPK13MAPK12MAPK11CSNK1D
SCHEMBL4586056 0.73 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11CSNK1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1264827-A1 Process for the preparation of Tosylbenzylformamides SMITHKLINE BEECHAM CORPORATION (US) 2002-12-11 EP disclosed
EP-0809499-A4 CERTAIN 1,4,5-TRI-SUBSTITUTED IMIDAZOLE COMPOUNDS USEFUL AS CYTOKINE SMITHKLINE BEECHAM CORP (US) 1998-10-14 EP disclosed
EP-0809499-A1 CERTAIN 1,4,5-TRI-SUBSTITUTED IMIDAZOLE COMPOUNDS USEFUL AS CYTOKINE SMITHKLINE BEECHAM CORPORATION (US) 1997-12-03 EP disclosed
WO-1996021452-A1 CERTAIN 1,4,5-TRI-SUBSTITUTED IMIDAZOLE COMPOUNDS USEFUL AS CYTOKINE SMITHKLINE BEECHAM CORPORATION (US) 1996-07-18 WO disclosed